Tutorials › High-Dimensional Genomic Data Analysis › Evaluating Replication Across Ancestry Groups

Ancestry-Aware Association and Cross-Population Portability · Tutorial 308 of 795

Evaluating Replication Across Ancestry Groups

Evaluate whether association evidence is consistent across ancestry groups by examining effect estimates, uncertainty, heterogeneity, and power in context.

Advanced 12 min read

What You'll Learn

  • Distinguish directional consistency from statistical significance in a replication sample.
  • Interpret ancestry-specific estimates and confidence intervals on a comparable effect scale.
  • Use heterogeneity evidence without treating a nonsignificant test as proof of equal effects.
  • Calculate approximate power for each ancestry group under stated assumptions.
  • Diagnose when differences in power, measurement, or study design complicate replication.
  • Avoid common errors such as comparing significance labels or equating overlapping intervals with equal effects.

What Counts as Replication Across Ancestry Groups?

An association found in one ancestry group may not reach a conventional significance threshold in another. That difference alone does not establish that the association failed to replicate: the groups may have different sample sizes, allele frequencies, or standard errors, even when their underlying effects are similar. Conversely, two significant results do not by themselves show that the effects are equal or that one result has independently replicated the other.

A careful assessment uses the estimated effects and their uncertainty, asks whether the estimates point in a consistent direction, and evaluates evidence for heterogeneity. It also considers how much power each group had to detect an effect of the relevant size. As established in the earlier material on allele harmonization and effect scales, alleles, effect directions, phenotypes, and scales must be aligned before estimates can be compared.

Definition: Cross-ancestry replication is evidence that an association observed in one ancestry group is also supported in another group for a harmonized variant, phenotype, effect scale, and analysis target. Directional consistency means the estimated effects have the same sign after harmonization. Neither directional consistency nor replication requires every ancestry-specific test to pass a chosen significance threshold.

Replication is best treated as an evidence assessment, not a binary label produced by one p-value. A replication analysis should specify in advance which group provides the discovery evidence, which group is the replication sample, the expected direction, the effect scale, and the statistical criterion. For a planned one-sided test, the direction must be prespecified; if direction was selected after seeing the replication data, a two-sided assessment is generally appropriate.

Estimates, Intervals, and Direction

Suppose \(\hat{\beta}_k\) is the estimated association effect in ancestry group \(k\), with standard error \(SE_k\). The estimate describes the direction and magnitude on the stated scale; its standard error describes sampling uncertainty under the fitted model. Under an approximate normal sampling distribution, a two-sided 95% confidence interval is \(\hat{\beta}_k \pm 1.96SE_k\). This interval gives a range of effect values compatible with the data and model at that confidence level; it is not a 95% probability statement about the fixed effect after the interval is observed.

The sign of \(\hat{\beta}_k\) is informative only when effect alleles and outcome coding are aligned. A positive estimate in one analysis and a negative estimate in another may reflect allele flips or coding differences rather than biological disagreement. Even with harmonization, a small estimate with a wide interval can have either sign because the data are imprecise. Thus, distinguish the point-estimate direction from the strength of evidence about direction.

Worked Example: Same Direction, Different Significance

Consider hypothetical independent discovery and replication samples analyzed on the same effect scale, with the same effect allele and covariates. Suppose the discovery estimate is \(0.08\) units per effect allele with \(SE=0.03\), and the replication estimate is \(0.04\) units with \(SE=0.03\). Assume the estimates are approximately normal and standard errors are valid.

In discovery, \(z=\hat{\beta}/SE=0.08/0.03=2.667\), giving a two-sided normal-approximation \(p\)-value of about \(0.0077\). The 95% interval is

$$ 0.08 \pm 1.96(0.03) =0.08\pm0.0588 =[0.0212,\ 0.1388]. $$

In replication, \(z=0.04/0.03=1.333\), with a two-sided \(p\)-value of about \(0.182\). Its 95% interval is

$$ 0.04 \pm 1.96(0.03) =0.04\pm0.0588 =[-0.0188,\ 0.0988]. $$

Both point estimates are positive, so the observed directions agree. The replication estimate is less precise relative to its size and its interval includes zero; its test does not meet the conventional 0.05 threshold. These results provide same-direction evidence but do not establish that the true effects are identical, nor do they alone prove replication under every prespecified criterion.

Comparing p-values or significance labels discards important information. A p-value depends on both the estimated effect and its standard error. A smaller study can estimate an effect in the same direction but have a larger p-value because its standard error is larger. For this reason, report the effect estimate, interval, and sample-specific evidence together.

Heterogeneity: Is There Evidence That Effects Differ?

Directional replication asks whether estimates point in the same direction. Heterogeneity analysis asks a different question: whether the effect estimates are more dispersed than would be expected from sampling error under a common-effect model. For independent estimates \(\hat{\beta}_1,\ldots,\hat{\beta}_K\) with standard errors \(SE_k\), an inverse-variance common-effect estimate is

$$ \hat{\beta}_{FE} = \frac{\sum_{k=1}^{K} w_k\hat{\beta}_k}{\sum_{k=1}^{K}w_k}, \qquad w_k=\frac{1}{SE_k^2}. $$

The Cochran heterogeneity statistic is \(Q=\sum_k w_k(\hat{\beta}_k-\hat{\beta}_{FE})^2\). Under independent, approximately normal estimates with a common true effect and valid standard errors, \(Q\) is approximately chi-square distributed with \(K-1\) degrees of freedom. A small p-value is evidence against the common-effect assumption. A large p-value does not prove equal effects: with few groups or imprecise estimates, the test may have low power to detect heterogeneity.

The common-effect calculation assumes that the estimates target comparable parameters and that their sampling errors are adequately characterized. Dependence between estimates, overlapping participants, or unmodeled uncertainty can invalidate the usual reference distribution unless accounted for. The heterogeneity test should therefore be interpreted alongside the estimates and intervals, not as a stand-alone verdict.

Worked Example: Interpreting a Heterogeneity Test

Suppose two hypothetical ancestry-specific studies estimate effects on the same scale: group A has \(\hat{\beta}_1=0.10\), \(SE_1=0.04\); group B has \(\hat{\beta}_2=0.02\), \(SE_2=0.03\). Assume the studies are independent, the allele and phenotype are harmonized, and both estimates have valid approximately normal sampling distributions.

The inverse-variance weights are \(w_1=1/0.04^2=625\) and \(w_2=1/0.03^2=1111.11\). Thus,

$$ \hat{\beta}_{FE} = \frac{625(0.10)+1111.11(0.02)}{625+1111.11} = \frac{84.7222}{1736.11} \approx0.0488. $$

The heterogeneity statistic is

$$ Q=625(0.10-0.0488)^2+1111.11(0.02-0.0488)^2 \approx1.639+0.921 =2.560. $$

With two estimates, \(df=1\); the chi-square upper-tail p-value is approximately \(0.110\). This is not strong evidence against a common effect at the 0.05 level, but it does not demonstrate that the effects are equal. The group-specific intervals are also informative: group A has \(0.10\pm1.96(0.04)=[0.0216,0.1784]\), while group B has \(0.02\pm1.96(0.03)=[-0.0388,0.0788]\). Both estimates are positive, but the second is imprecise.

Do not use interval overlap as a substitute for a heterogeneity test. Overlap is not the test of the difference between estimates; the uncertainty of a difference depends on the standard errors and their covariance. With independent estimates, the standard error of \(\hat{\beta}_1-\hat{\beta}_2\) is \(\sqrt{SE_1^2+SE_2^2}\). If samples overlap, covariance must also be considered.

Ancestry-Specific Power and Interpretation

A nonsignificant result is more informative when a study had substantial power to detect an effect of scientific interest. Under a normal approximation, if the true effect is \(\beta\) and its standard error is \(SE\), the test statistic has approximate distribution \(N(\delta,1)\), where \(\delta=\beta/SE\). For a two-sided test at level \(\alpha\), approximate power is

$$ P(Z>z_{1-\alpha/2}-\delta) + P(Z<-z_{1-\alpha/2}-\delta), \qquad Z\sim N(0,1). $$

This calculation assumes a prespecified effect size, valid standard error, correct model, and the specified testing threshold. In ancestry-stratified analyses, power can differ because sample sizes and allele frequencies differ, among other reasons. Differences in power do not themselves explain a particular observed effect difference, but they help calibrate how much weight to place on a nonsignificant result.

Worked Example: Comparing Approximate Power

Assume a hypothetical common effect of \(0.06\) outcome units per allele and a two-sided test with \(\alpha=0.05\). Suppose one ancestry group has \(SE=0.03\), while another has \(SE=0.045\). Treat both standard errors as known for this normal approximation and assume the model and effect scale are appropriate.

For the first group, \(\delta=0.06/0.03=2.000\). Its approximate power is

$$ P(Z>1.96-2.000)+P(Z<-1.96-2.000) =\Phi(0.040)+\Phi(-3.960) \approx0.516. $$

For the second group, \(\delta=0.06/0.045=1.333\). Its approximate power is

$$ P(Z>1.96-1.333)+P(Z<-1.96-1.333) =\Phi(-0.627)+\Phi(-3.293) \approx0.266. $$

Under these assumptions, the second group has only about 27% power to detect the specified effect, compared with about 52% for the first. A nonsignificant result in that lower-power group would therefore be weak evidence against an effect of \(0.06\). These power values are conditional on the assumed effect and model; they are not probabilities that the effect is true.

Diagnostics, Alternatives, and Limitations

Before drawing a replication conclusion, verify that the comparisons are meaningful. Check allele alignment and strand handling, outcome coding, effect scale, phenotype definition, covariate adjustment, and analysis model. Review ancestry-specific sample sizes, allele counts or frequency, missingness, imputation quality, and calibration diagnostics. A reversed effect allele can create an apparent direction reversal; sparse data or poor calibration can make an estimate unstable. Large discovery estimates can also be inflated by selection, so a smaller independent estimate is not automatically evidence of biological nonreplication.

The main approaches answer related but distinct questions. A direction check is simple and useful for assessing sign consistency, but it ignores precision and magnitude. Comparing estimates and confidence intervals makes both visible, but interval overlap is not a formal equality test. A heterogeneity test evaluates dispersion beyond sampling error, but can have low power and depends on its assumptions. An ancestry-specific power calculation contextualizes a null result, but depends on the assumed effect and does not prove that low power caused the result.

These tools also have limits. Statistical compatibility across groups does not establish a shared causal mechanism, and apparent heterogeneity can arise from differences in tagging, measurement, or model specification as well as effect variation. A p-value above a threshold is not evidence that the null is true; a p-value below it is not a measure of effect size. Report estimates and uncertainty in context, and avoid treating socially defined ancestry categories as homogeneous biological populations.

Common pitfall: “The association replicated in group A because its p-value is below 0.05, but failed in group B because its p-value is above 0.05.” This reasoning compares two significance labels, not the effects. Instead, compare harmonized estimates and directions, inspect their intervals, assess heterogeneity, and consider each group’s power to detect a relevant effect.

A practical conclusion should be calibrated: for example, “The two estimates have the same positive direction; the replication estimate is less precise and its interval includes zero, while the heterogeneity test provides limited evidence of a difference.” Such wording communicates what the data show without claiming either exact equality or definitive failure.

Check Your Understanding

Answer each question, then compare with the solutions.

  1. A replication estimate is positive but its 95% interval includes zero. What can and cannot be concluded about its direction and significance?
  2. Why does a heterogeneity-test p-value above 0.05 not establish equal effects?
  3. For independent estimates \(0.12\) with \(SE=0.04\) and \(0.04\) with \(SE=0.04\), calculate the standard error and \(z\)-statistic for their difference.
  4. Why might two ancestry groups have different significance results even if their underlying effects are the same?

Solutions. (1) The point estimate is positive, but the interval includes zero, so the data do not establish a nonzero positive effect at the corresponding two-sided 0.05 level. (2) The test may have low power, especially with few groups or imprecise estimates; failure to reject is not proof of equality. (3) The estimated difference is \(0.12-0.04=0.08\); its standard error is \(\sqrt{0.04^2+0.04^2}=\sqrt{0.0032}\approx0.0566\), so \(z=0.08/0.0566\approx1.414\). (4) Different sample sizes, allele frequencies, and residual variability can yield different standard errors and power, so the same underlying effect can produce different p-values.

Clinical Biostats